Portsmouth University Hospital, UK.
Clin Med (Lond). 2024 May;24(3):100217. doi: 10.1016/j.clinme.2024.100217. Epub 2024 May 6.
Statin-induced immune-mediated necrotising myopathy (IMNM) is an inflammatory myopathy that can present as proximal muscle weakness and, in some cases, as dysphagia and respiratory distress. In this report, we present a case of statin-induced IMNM in a 78-year-old male. The patient had significantly high levels of creatinine kinase and myoglobinuria and experienced gradual weakness in the proximal muscles for 1 month after initiating a 20 mg dose of Atorvastatin 10 months before admission. Rapid clinical improvement was observed with the use of high-dose glucocorticoids in conjunction with methotrexate.
他汀类药物引起的免疫介导的坏死性肌病(IMNM)是一种炎症性肌病,可表现为近端肌无力,在某些情况下还可表现为吞咽困难和呼吸窘迫。在本报告中,我们介绍了一例 78 岁男性的他汀类药物引起的 IMNM。患者在入院前 10 个月开始服用阿托伐他汀 20mg 时,肌酸激酶和肌红蛋白尿显著升高,且出现逐渐的近端肌无力,持续 1 个月。使用大剂量糖皮质激素联合甲氨蝶呤治疗后,患者的病情迅速改善。